We are live on ! Find out more
ACM

Apex Capital Management Portfolio holdings

AUM $4.54B
1-Year Est. Return 1.74%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+1.74%
3 Year Est. Return
+80.63%
5 Year Est. Return
10 Year Est. Return
AUM
$3.25B
AUM Growth
+$423M
Cap. Flow
+$286M
Cap. Flow %
8.79%
Top 10 Hldgs %
19.1%
Holding
281
New
16
Increased
159
Reduced
67
Closed
18

Sector Composition

Rank Sector Weight
1 Industrials 21.6%
2 Consumer Discretionary 20.23%
3 Technology 13.14%
4 Healthcare 10.62%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLB icon
51
Dolby
DLB
$4.9B
$29.1M 0.9%
674,133
+70,396
+12% +$2.94M
ENS icon
52
EnerSys
ENS
$6.74B
$28.7M 0.88%
416,518
+45,622
+12% +$3.1M
ENTG icon
53
Entegris
ENTG
$17.8B
$28.2M 0.87%
2,052,248
-17,268
-0.8% -$205K
BITA
54
DELISTED
Bitauto Holdings Limited
BITA
$28.2M 0.87%
+579,010
New +$22.7M
FNSR
55
DELISTED
Finisar Corp
FNSR
$27.3M 0.84%
1,383,130
+139,211
+11% +$3.35M
ALB icon
56
Albemarle
ALB
$13.9B
$27.3M 0.84%
381,750
+39,719
+12% +$2.73M
JAZZ icon
57
Jazz Pharmaceuticals
JAZZ
$16.2B
$26.3M 0.81%
179,192
+106,025
+145% +$14.7M
GNC
58
DELISTED
GNC Holdings, Inc.
GNC
$24.8M 0.76%
728,165
+75,216
+12% +$3M
PRXL
59
DELISTED
Parexel International Corp
PRXL
$24.2M 0.74%
457,339
+48,473
+12% +$2.43M
JOYY
60
JOYY Inc
JOYY
$3.68B
$24M 0.74%
+317,762
New +$20.7M
GNTX icon
61
Gentex
GNTX
$5.03B
$23.6M 0.73%
1,625,306
+172,984
+12% +$2.53M
ZU
62
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$23.5M 0.72%
+574,348
New +$23.1M
MDVN
63
DELISTED
MEDIVATION, INC.
MDVN
$22M 0.68%
570,814
+58,938
+12% +$1.99M
TIVO
64
DELISTED
Tivo Inc
TIVO
$21.8M 0.67%
910,799
+96,648
+12% +$2.24M
INFA
65
DELISTED
INFORMATICA CORP
INFA
$21.4M 0.66%
601,337
+62,451
+12% +$2.3M
NSR
66
DELISTED
Neustar Inc
NSR
$20.4M 0.63%
782,886
+337,578
+76% +$9.17M
CSTM icon
67
Constellium
CSTM
$3.89B
$20.3M 0.62%
633,633
+82,411
+15% +$2.48M
PRLB icon
68
Protolabs
PRLB
$1.79B
$19.2M 0.59%
+234,436
New +$15.9M
NTCT icon
69
NETSCOUT
NTCT
$2.91B
$18.2M 0.56%
410,130
+61,534
+18% +$2.39M
KERX
70
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$17.2M 0.53%
1,119,172
+214,859
+24% +$3.05M
GOOG icon
71
Alphabet (Google) Class C
GOOG
$4.08T
$16M 0.49%
551,711
-4,125
-0.7% -$112K
IBKR icon
72
Interactive Brokers
IBKR
$40.3B
$15.5M 0.48%
2,666,792
+289,052
+12% +$1.66M
MANH icon
73
Manhattan Associates
MANH
$11.1B
$15M 0.46%
434,722
+46,300
+12% +$1.53M
UTHR icon
74
United Therapeutics
UTHR
$26.2B
$13.7M 0.42%
154,380
+15,532
+11% +$1.49M
AAPL icon
75
Apple
AAPL
$4.9T
$13M 0.4%
557,796
-22,756
-4% -$484K

Similar funds

Apex Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Apex Capital Management held 281 positions worth $3.25B, up 15% from $2.83B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Apex Capital Management deployed $286M of net new capital in Q2 2014, opening 16 new positions and adding to 159 existing holdings. Its largest new stake was Core Laboratories: 181,100 shares worth $30.3M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AOL INC COMMON STOCK, an estimated $28.7M trimmed.

  • Apex Capital Management's largest Q2 2014 buy was Core Laboratories: 181,100 shares worth $30.3M.
  • Apex Capital Management added most to Centene in Q2 2014, an estimated $24.9M increase.
  • Apex Capital Management's biggest Q2 2014 reduction was AOL INC COMMON STOCK, cutting an estimated $28.7M.
  • Apex Capital Management fully exited Mercado Libre in Q2 2014, selling an estimated $36.9M.
  • Apex Capital Management's ten largest holdings make up 19% of its $3.25B portfolio in Q2 2014.
  • Apex Capital Management opened 16 new positions and closed 18 in Q2 2014.
  • Apex Capital Management's portfolio value rose 15% quarter-over-quarter to $3.25B.

Based on Apex Capital Management's 13F filing for Q2 2014, filed 15 Jul 2014.